A single dose of ketamine, the anesthetic drug that has been found to have fast-acting antidepressant effects, can significantly reduce suicidal thoughts in patients with depression for up to a week, according to a new analysis.
Thoughts of suicide in patients with bipolar disorder declined significantly within 24 hours following treatment with ketamine, according to a small randomized trial reported April 28 in the journal
Animal research reported on March 21 in the journal Molecular Psychiatry has uncovered a drug development strategy that could lead to a new type of antidepressant medication.
Donations are welcome
100% of your contributions for research are invested in our grants to scientists thanks to the generous support of two family foundations which cover our operating expenses.
The Brain & Behavior Research Foundation is a 501(c)(3) nonprofit organization, our Tax ID # is 31-1020010.